Abcam (ABCZY) News Today → The World's First '$20 Trillion Drug?' (From Behind the Markets) (Ad) Free ABCZY Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLong-standing Danaher executive Markus Lusser becomes new president of Abcammsn.com - March 18 at 5:22 PMAbcam appoints Markus Lusser as new Presidentfinance.yahoo.com - March 18 at 12:22 PMDanaher deal for Abcam approved by 89 per cent of shareholdersmsn.com - November 7 at 8:53 AMAbcam shareholders approve $5.7 billion Danaher dealuk.news.yahoo.com - November 6 at 7:40 PMAbcam founder ends fight to block takeoverthetimes.co.uk - November 1 at 11:05 PMLeading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote "FOR" Danaher Corporation’s Proposed Acquisition of Abcamfinance.yahoo.com - October 23 at 7:54 AMEfforts to stop takeover of biotech firm Abcam dealt a blowmsn.com - October 21 at 6:11 PMTop Abcam Investor HBK Voices Support for $5.7 Billion Salemsn.com - October 19 at 12:19 AMLeading Proxy Advisor, ISS, Recommends Shareholders Vote "FOR" Danaher Corporation's Proposed Acquisition of Abcamstockhouse.com - October 17 at 9:03 AMExlusive: Why Abcam founder believes Danaher's acquisition offer falls shortproactiveinvestors.com - October 16 at 9:59 AMHBK Capital Becomes Biggest Abcam Investor, Set to Support Salemsn.com - October 16 at 9:59 AMAbcam founder's concern over exodus of British life science companiesmsn.com - October 14 at 7:42 PMAbcam founder speaks out against growing exodus of British life science companiesmsn.com - October 14 at 7:42 PMIndependent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to Danaherfinance.yahoo.com - October 12 at 9:37 AMAbcam received multiple bids in sales process, contacted over 30 partiesmsn.com - October 5 at 4:32 PMLife sciences group Abcam rejects founder’s accusations over $5.7bn deal with Danaherft.com - October 5 at 11:32 AMAbcam challenger hits out as process to set EGM date goes onmsn.com - October 4 at 12:22 PMAbcam founder slams £4.5bn sale to US conglomerate Danahermsn.com - September 28 at 6:01 PMUK Life Sciences Firm Abcam’s Founder Fights $5.7 Billion Bidca.news.yahoo.com - September 28 at 8:00 AMUPDATE 3-Abcam founder seeks to block $5.7 billion Danaher dealmsn.com - September 15 at 2:01 PMSignal: Danaher’s $5.7bn acquisition of Abcam faces stand-off with foundermsn.com - September 15 at 9:01 AMAbcam plc Statement on Dr. Jonathan Milner’s Announcementfinance.yahoo.com - September 14 at 7:13 PMAbcam founder Jonathan Milner renews clear-out bidthetimes.co.uk - September 14 at 7:13 PMAbcam plc founder to vote against proposed $5.7B Danaher acquisition, believes offer undervalues the companyinvesting.com - September 14 at 2:13 PMDr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace Boardfinance.yahoo.com - September 14 at 9:12 AMAbcam founder Jonathan Milner opposes Danaher dealinvesting.com - September 14 at 9:12 AMAbcam founder to vote against proposed $5.7bn acquisition by US Danaherft.com - September 14 at 9:12 AMAbcam founder calls on board to justify takeover bidthetimes.co.uk - September 6 at 10:59 PMAbcam founder, holder Jonathan Milner still evaluating Danaher deal - reportmsn.com - August 31 at 1:05 PMDanaher's Strategic Abcam Deal Boosts Growth at a Reasonable Price: Analystmarkets.businessinsider.com - August 29 at 4:10 PMDanaher agrees to acquire UK’s Abcam for $5.7bnmsn.com - August 29 at 4:42 AMAbcam agrees $5.7bn US takeover dealthetimes.co.uk - August 28 at 11:42 PMUS medical giant Danaher lands UK life-science firm Abcam in £4.5bn dealmsn.com - August 28 at 6:41 PMAbcam holder Milner expects to speak to holders next week on Danaher deal - reportmsn.com - August 28 at 6:41 PMBritish biotech firm Abcam snapped up by Danaher for £4.5bnmsn.com - August 28 at 1:41 PMDanaher to Acquire Abcamtechnews.tmcnet.com - August 28 at 8:22 AMDanaher to acquire Abcam for $5.7 billionza.investing.com - August 28 at 8:22 AMDanaher to acquire Abcam for $24.00 per Sharetechnews.tmcnet.com - August 28 at 8:22 AMExpert Ratings for Abcammarkets.businessinsider.com - August 22 at 5:16 PMAbcam plc: All Resolutions Withdrawn at Abcam's EGMfinance.yahoo.com - July 12 at 10:31 AMBiotech supplier Abcam is closing its 2nd Bay Area location this year and cutting 43 more workersbizjournals.com - July 5 at 8:54 PMAbcam founder Jonathan Milner suspends proxy solicitation (update)msn.com - June 27 at 9:15 AMJonathan Milner ends bid to become executive chairman of Abcam plc – for nowmsn.com - June 27 at 9:15 AMAbcam founder Jonathan Milner backs down in board overhaul rowthetimes.co.uk - June 27 at 9:15 AMBiotech firm Abcam looks for a buyer as investor feud with founder intensifiesthetimes.co.uk - June 23 at 6:15 PMWhy Shares of Abcam Are Jumping Fridaymsn.com - June 23 at 6:15 PMAbcam Shares Up 11% on Board Exploring Strategic Alternativesmarketwatch.com - June 23 at 1:15 PMAbcam Rises 8% As It Explores Possible Salemarkets.businessinsider.com - June 23 at 1:15 PMWhy Abcam Shares Are Soaring Todaymsn.com - June 23 at 1:15 PMAbcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipationmarkets.businessinsider.com - June 20 at 3:01 PM Get Abcam News Delivered to You Automatically Sign up to receive the latest news and ratings for ABCZY and its competitors with MarketBeat's FREE daily newsletter. Email Address The World's First "$20 Trillion Drug?" (Ad)One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%! Get the name of the stock here >>> ABCZY Media Mentions By Week ABCZY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABCZY News Sentiment▼0.000.41▲Average Medical News Sentiment ABCZY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABCZY Articles This Week▼01▲ABCZY Articles Average Week Get Abcam News Delivered to You Automatically Sign up to receive the latest news and ratings for ABCZY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ITGR News Today GNNDY News Today ALKS News Today PRGO News Today IMVT News Today CBAY News Today ALPN News Today AMBBY News Today IBRX News Today RARE News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ABCZY) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abcam plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
